Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304

NCT01457989 · clinicaltrials.gov ↗

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy, Partial

Interventions

DRUG: retigabine/ezogabine

Sponsor

GlaxoSmithKline